Literature DB >> 17100890

Natural killer cells and malaria.

Sophie Roetynck1, Myriam Baratin, Sofia Johansson, Céline Lemmers, Eric Vivier, Sophie Ugolini.   

Abstract

Malaria, caused by the infection with parasites of the germs Plasmodium, is one of the three most important infectious diseases worldwide, along with tuberculosis and infection with human immunodeficiency virus. Natural killer (NK) cells are lymphocytes classically involved in the early defense against viral infections and intracytoplasmic bacterial infections and are also implicated during the course of tumor development and allogeneic transplantation. These cells display important cytotoxic activity and produce high levels of proinflammatory cytokines. In both mouse and human models of malaria, NK cells appear to be a major source of interferon-gamma during the early phase of infection. In humans, indirect signaling through monocytes/macrophages required to optimally stimulate NK cell activity. However, the in vivo functions of NK cells during malaria are still enigmatic, and many issues remain to be dissected, such as the molecular basis of the direct recognition of iRBCs by NK cells.

Entities:  

Mesh:

Year:  2006        PMID: 17100890     DOI: 10.1111/j.1600-065X.2006.00446.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  15 in total

1.  NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant.

Authors:  Lindsay J Hall; Simon Clare; Gordon Dougan
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

2.  Gammadelta T cells but not NK cells are essential for cell-mediated immunity against Plasmodium chabaudi malaria.

Authors:  William P Weidanz; GayeLyn LaFleur; Andrew Brown; James M Burns; Irene Gramaglia; Henri C van der Heyde
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

3.  Pretreatment with Cry1Ac protoxin modulates the immune response, and increases the survival of Plasmodium-infected CBA/Ca mice.

Authors:  Martha Legorreta-Herrera; Rodrigo Oviedo Meza; Leticia Moreno-Fierros
Journal:  J Biomed Biotechnol       Date:  2010-03-11

Review 4.  The Yin and Yang of HLA and KIR in human disease.

Authors:  Smita Kulkarni; Maureen P Martin; Mary Carrington
Journal:  Semin Immunol       Date:  2008-07-16       Impact factor: 11.130

5.  Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells.

Authors:  Qingfeng Chen; Anburaj Amaladoss; Weijian Ye; Min Liu; Sara Dummler; Fang Kong; Lan Hiong Wong; Hooi Linn Loo; Eva Loh; Shu Qi Tan; Thiam Chye Tan; Kenneth T E Chang; Ming Dao; Subra Suresh; Peter R Preiser; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 6.  Human natural killer cells.

Authors:  Michael A Caligiuri
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

7.  Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.

Authors:  Han Wang; Jianxun Qi; Shuijun Zhang; Yan Li; Shuguang Tan; George F Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

8.  Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy.

Authors:  Caroline Othoro; Julie M Moore; Kathleen A Wannemuehler; Sichangi Moses; Altaf Lal; Juliana Otieno; Bernard Nahlen; Laurence Slutsker; Ya Ping Shi
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

9.  Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity.

Authors:  Lili Chen; Zhengxiang He; Li Qin; Qinyan Li; Xibao Shi; Siting Zhao; Ling Chen; Nanshan Zhong; Xiaoping Chen
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

10.  Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.

Authors:  Kouyuki Hirayasu; Jun Ohashi; Koichi Kashiwase; Hathairad Hananantachai; Izumi Naka; Atsuko Ogawa; Minoko Takanashi; Masahiro Satake; Kazunori Nakajima; Peter Parham; Hisashi Arase; Katsushi Tokunaga; Jintana Patarapotikul; Toshio Yabe
Journal:  PLoS Pathog       Date:  2012-03-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.